0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn’s disease" gave back 39274 results.
Smart pill technology is a revolutionary technological innovation that has reduced the gap between healthcare and digital technology. Smart pills or...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Intercellular Adhesion Molecule 1 - Pipeline Review, H2 2019 Summary Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2018 Summary Integrin Alpha 4 (...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or...
Catalog:
Global Markets Direct
December 2021
Price: USD 3,500.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Remicade (Infliximab) Monoclonal Antibody market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019 Summary Intercellular Adhesion...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- Global (38897) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Markets (1) Apply Emerging Markets filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
